CRE-ating Success: How I Use Rapid Diagnostic Tests to Manage Carbapenem-Resistant Enterobacterales Bacteremia
Hear Julie Ann Justo, PharmD, MS, FIDSA, BCPS, share her approach to treating CRE infections through a patient case, including a review of the changing epidemiology of CRE, contributing mechanisms of resistance, and current IDSA guidance recommendations based on the latest data.
Decera Clinical Education Infectious Disease Podcast · Julie Ann Justo PharmD MS FIDSA BCPS
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including:
- Burden of CRE infections in the United States
- Mechanisms of resistance
- Changing epidemiology
- Use of rapid diagnostic tests
- IDSA guidance recommendations, including supporting data
- Approach to designing treatment regimens, including weighing patient- and infection-related factors
Faculty:
Julie Ann Justo, PharmD, MS, FIDSA, BCPS
Clinical Pharmacist Lead – Infectious Diseases
Inpatient Pharmacy
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire
Link to full program:
https://bit.ly/41a8Mj0
Link to accompanying ClinicalThought commentary:
https://bit.ly/4865T57
Link to downloadable infographic:
https://bit.ly/3t7NpT2
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.